Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients

BACKGROUND: The utility of convalescent coronavirus disease 2019 (COVID-19) plasma (CCP) in the current pandemic is not well defined. We sought to evaluate the safety and efficacy of CCP in severely or life threateningly ill COVID-19 patients when matched with a contemporaneous cohort. METHODS: Pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Klapholz, Marc, Pentakota, Sri Ram, Zertuche, Juan-Pablo, McKenna, Marshall, Roque, Willy, Forsberg, Mark, Packer, Johnathan, Lal, Devika S, Dever, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798482/
https://www.ncbi.nlm.nih.gov/pubmed/33604400
http://dx.doi.org/10.1093/ofid/ofab001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798482/
https://www.ncbi.nlm.nih.gov/pubmed/33604400
http://dx.doi.org/10.1093/ofid/ofab001

Ejemplares similares